EVENT: BLADERUNNER / SYMPTOM – 24.01.14

0

blade-runnner-post

Heavyweight launches with a hefty line up at The Cellar this January. To kick things off, they have a treat for all the drum and bass fans out there: On Friday 24th January 2014 they’re bringing Bladerunner (Dread, Crtical, Program) and Sympton (one half of the legendary Savage Rehab) to Southampton. Also lined up are Contra, Rushmoor, and Blancx. Tickets are £8 advance.

TICKETS VIA FATSOMA

By now Bladerunner is a man who shouldn’t really need an introduction. A scene stalwart for many years and also one of the most prolific remixers in the game, his status is pretty much certified. Bladerunner’s new school, forward thinking take on the classic jungle sound has won him legions of fans from heads to producers alike with tracks such as “Back To The Jungle” on Crtical, “Feel For You” on Dread, and his massive rework of DJ SS’ classic “Black”.

Symptom (Savage Rehab) is a producer who has much love for drum and bass in all its forms, proving it once more with this release featuring two stunners showing just how diverse a producer he can be. The first track “Drama” is a piece of pure liquid elegance that opens with its acoustic strings, rolling bassline, sparkling pads and crisp beats. The second track “Denial” is Drama’s bad boy brother with its Amen breaks punching up through some amazing vocals whilst the bass just holds it all in place tightly, definitely a dancefloor smasher!

Contra, AKA Bradley, Max, Charlie and Chris play the music they love at clubs across the country. The Bristol/London based producer/DJs have combined their production skills with a unique approach to mixing, including 4 turntables and the freshest tunes. This is not a set to be missed.

TICKETS VIA FATSOMA

2014-01-24-heavyweight

TICKETS VIA FATSOMA

Share.

About Author

Adam is a physics graduate from the University of Southampton with an interest in electronic music. He co-founded Sotonight and was involved with SEMSU and other music-related projects while at university.

Comments are closed.